Enzymatica Q3 Oper Loss Widens To SEK 12.6 Mln

T-Reuters
Nov 02, 2022

Enzymatica AB (publ) :Interim Report Q3/2022: A Broader Role For Coldzyme Adds Potential For The Future.Q3 Net Sales Reached Sek 18.5 (15.4) Million..Q3 Operating Result Totaled Sek -12.6 (-6.0) Million..

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10